Encompass Health Corporation
EHC · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $5 | $5 | $4 | $4 |
| % Growth | 11.9% | 10.4% | 8.3% | – |
| Cost of Goods Sold | $3 | $3 | $3 | $2 |
| Gross Profit | $2 | $2 | $2 | $2 |
| % Margin | 41.6% | 41.3% | 40.3% | 42.4% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $1 | $0 | $1 | $1 |
| Operating Expenses | $1 | $0 | $1 | $1 |
| Operating Income | $1 | $2 | $1 | $1 |
| % Margin | 16.1% | 35.9% | 14.5% | 16.4% |
| Other Income/Exp. Net | -$0 | -$1 | -$0 | -$0 |
| Pre-Tax Income | $1 | $1 | $0 | $1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 8.5% | 7.3% | 6.2% | 10.3% |
| EPS | 4.53 | 3.54 | 2.72 | 4.15 |
| % Growth | 28% | 30.1% | -34.5% | – |
| EPS Diluted | 4.46 | 3.47 | 2.7 | 4.11 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $1 | $1 | $1 | $1 |
| % Margin | 22.1% | 20.9% | 20% | 22.1% |